首页 | 本学科首页   官方微博 | 高级检索  
     

尿激酶型纤溶酶原激活物受体的研究进展及与脑室出血纤溶治疗的关系
引用本文:罗自勉. 尿激酶型纤溶酶原激活物受体的研究进展及与脑室出血纤溶治疗的关系[J]. 医学综述, 2011, 17(22): 3395-3397
作者姓名:罗自勉
作者单位:湖南省湘潭市中心医院,湖南,湘潭,411100
摘    要:尿激酶型纤溶酶原激活物受体是近几年基础研究的热点,由它介导的功能包括纤溶降解、细胞迁移、趋化作用、细胞黏附、信号转导等,但其主要功能是纤溶降解。目前向脑室内注射尿激酶联合脑室外引流是治疗脑室出血患者的公认纤溶方法,因此人类脑室系统是否具有尿激酶型纤溶酶原激活物受体、是否具有纤溶能力已成为临床医师关注的焦点。现就此相关问题加以综述。

关 键 词:尿激酶型纤溶酶原激活物受体  脑室出血  尿激酶

Research Progress of Urokinase-type Plasminogen Activator Receptor and Its Function in the Fibrinolytic Treatment of Intraventricular Hemorrhage
LUO Zi-mian. Research Progress of Urokinase-type Plasminogen Activator Receptor and Its Function in the Fibrinolytic Treatment of Intraventricular Hemorrhage[J]. Medical Recapitulate, 2011, 17(22): 3395-3397
Authors:LUO Zi-mian
Affiliation:LUO Zi-mian,ZHOU Xin-fu.(Xiangtan City Central Hospital,Xiangtan 411100,China)
Abstract:Urokinase-type plasminogen activator receptor(uPAR)is a focus of basic research in recent years.Functions mediated by uPAR include fibrinolysis,cell migration,chemotaxis,cell adhesion,signal transduction,etc.,while the main function of uPAR is to mediate fibrinolysis.At present,external ventricular drainage plus intraventricular infusion of urokinase has been a generally accepted method to treat patients with severe intraventricular hemorrhage.Therefore,Clinicians are paying more attention to questions whet...
Keywords:Urokinase-type plasminogen activator receptor  Intraventricular hemorrhage  Urokinase  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号